Ad chides Gilead "greed" over Sovaldi pricing

Share this article:

The AIDS Healthcare Foundation (AHF) took out an ad in today's Wall Street Journal blasting Gilead and “our state and federal leaders,” whom the coalition charges with “breaking the bank by paying whatever Gilead and its pharma allies demand without question.”

The half-page, four-color ad was slated to run in WSJ editions in Northern California and the Washington/Maryland/Virginia markets, AHF said, coinciding with Gilead's Annual General Meeting in Millbrae, CA.

The headline of the ad reads:


The nonprofit AIDS organization has been a frequent critic of drug pricing and has been vocal before.

In January, the group's leader—Michael Weinstein—also referred to Gilead's HIV prevention treatment, Truvada, as a “party drug,” amid reports from the New York Times about the drug's stigma in the gay community.  

And in 2007 the group went so far as to file a suit with Pfizer over its DTC campaign for ED drug Viagra. AHF accused Pfizer of promoting recreational use of Viagra and suggested a link between the drug and illicit methamphetamine use. A Pfizer spokesperson at the time denied the claims and added that AHF had approached the company, “with a multimillion-dollar funding request for a crystal meth educational program.”

Share this article:

Next Article in Business Briefs

Email Newsletters

More in Business Briefs

AstraZeneca takes on pediatricians

The American Academy of Pediatricians says an AstraZeneca drug for preemies should be used less often, and the drugmaker is fighting back with an ad campaign that says the new guidelines put too many at risk.

UK generic use soared in 2013

Generics made up almost 75% of prescriptions in the United Kingdom last year.

GSK refutes consumer spin-off rumor

The company refutes a Financial Times rumor that one was happening soonish.